Guardant Health's Shield blood test for colorectal cancer screening is now covered by TRICARE, providing active duty service ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

A second blood test shows promise for the detection of colon cancer, according to a new study. The first, called Shield, was approved by the Food and Drug Administration in July for people 45 and ...

Guardant Health, Inc., a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening is now covered for active-duty service members and their families ...

More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...

An investigational blood test for early detection of colorectal cancer (CRC) in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC study, the largest study ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

A new FDA-approved blood test designed to detect colon cancer earlier is now available in North Texas. An estimated 154,270 people in the U.S. will be diagnosed with colorectal cancer this year. It's ...

When you breathe out, you’re not just releasing carbon dioxide. Your breath carries a complex mix of volatile organic compounds, or VOCs—tiny molecules that come from normal body processes. These ...